PPC
AMGN icon

Park Place Capital’s Amgen AMGN Stock Holding History

Park Place Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$477K Sell
1,354
-496
-27% -$177K 0.1% 125
2025
Q4 		$606K Sell
1,850
-227
-11% -$72K 0.13% 108
2025
Q3 		$586K Buy
2,077
+13
+0.6% +$3.77K 0.12% 111
2025
Q2 		$600K Buy
2,064
+135
+7% +$38.2K 0.14% 110
2025
Q1 		$601K Buy
1,929
+4
+0.2% +$1.18K 0.16% 102
2024
Q4 		$502K Sell
1,925
-125
-6% -$37.1K 0.14% 120
2024
Q3 		$660K Sell
2,050
-633
-24% -$207K 0.19% 108
2024
Q2 		$838K Sell
2,683
-964
-26% -$283K 0.27% 80
2024
Q1 		$1.04M Sell
3,647
-1,449
-28% -$424K 0.37% 73
2023
Q4 		$1.47M Sell
5,096
-1,857
-27% -$506K 0.58% 45
2023
Q3 		$1.87M Buy
6,953
+326
+5% +$81.4K 0.55% 38
2023
Q2 		$1.47M Buy
6,627
+923
+16% +$214K 0.42% 51
2023
Q1 		$1.38M Buy
5,704
+688
+14% +$169K 0.39% 56
2022
Q4 		$1.32M Buy
+5,016
New +$1.34M 0.37% 57

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Park Place Capital's AMGN Position: Q1 2026 in Review

Park Place Capital reduced its Amgen (AMGN) stake by 27% in Q1 2026, selling an estimated $177K and leaving 1,354 shares worth $477K. The position accounts for 0.1% of the portfolio, ranked #125.

Park Place Capital first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.87M in Q3 2023. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Park Place Capital held 1,354 shares of Amgen worth $477K as of Q1 2026.
  • Park Place Capital sold 496 Amgen shares in Q1 2026, an estimated $177K.
  • Amgen made up 0.1% of Park Place Capital's portfolio in Q1 2026, its #125 holding.
  • Park Place Capital first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Park Place Capital's Amgen position peaked at $1.87M in Q3 2023.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.